How real-world data is powering rare disease research Part 3. RWD advances in China

Published on: Apr 18, 2025

As real-world data (RWD) transforms the drug development landscape, its power to advance research is becoming tangible in the most challenging therapeutic arena—rare diseases. In this series, Parexel experts discuss current initiatives in North America, Europe and China that are accelerating the use of RWD in rare disease research.
 

Download the whitepaper for China

Return to Insights Center

Related Insights

Whitepaper

How real-world data is powering rare disease research Part 2. RWD advances in Europe

Apr 18, 2025

Whitepaper

How real-world data is powering rare disease research Part 1. RWD advances in North America

Apr 18, 2025

Blog

Studying rare cancer patient populations using integrated genomic and real-world data

Aug 30, 2023

Blog

Advancing rare disease research: Exploring opportunities for Bayesian methods with FDA’s upcoming guidance

Jun 17, 2025

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Webinar

Adaptive strategies for more efficient, data-rich and patient-friendly trials

May 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Video

The science and practice of ethnobridging

May 17, 2023

Webinar

China's Market Approval Policy and Medical Insurance Payment System for Rare Disease

Jul 21, 2022

Playbook

Are you using real-world evidence?

Feb 1, 2023

Related Insights

Whitepaper

How real-world data is powering rare disease research Part 2. RWD advances in Europe

Apr 18, 2025

Whitepaper

How real-world data is powering rare disease research Part 1. RWD advances in North America

Apr 18, 2025

Blog

Studying rare cancer patient populations using integrated genomic and real-world data

Aug 30, 2023

Blog

Advancing rare disease research: Exploring opportunities for Bayesian methods with FDA’s upcoming guidance

Jun 17, 2025

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Show more